Transient Thyroid Dysfunction in New-Onset Type 1 Diabetes: Reassessing Test Timing for Accurate Results

Talha Üstüntaş1, Mehmet Emre Atabek2, Beray Selver Eklioğlu2

  • 1Department of Pediatrics, Necmettin Erbakan University, Konya, Türkiye.

PubMed

Insights

Thyroid function in children with new-onset Type 1 diabetes mellitus (T1DM) often normalizes within two weeks. Immediate thyroid testing is recommended for those with existing thyroid disease or symptoms.

Area of Science:

  • Pediatric Endocrinology
  • Diabetology
  • Thyroidology

Background:

  • Type 1 diabetes mellitus (T1DM) is a common childhood endocrine disorder requiring comprehensive management.
  • Thyroid dysfunction is a known comorbidity in T1DM patients.
  • Understanding the temporal dynamics of thyroid function in newly diagnosed T1DM is crucial for appropriate clinical care.

Purpose of the Study:

  • To determine the prevalence of thyroid dysfunction at diagnosis in pediatric T1DM patients.
  • To investigate the long-term thyroid function status through periodic monitoring.
  • To establish optimal timing for thyroid function testing in this population.

Main Methods:

  • Retrospective cohort study of 208 pediatric patients with newly diagnosed T1DM.
  • Analysis of medical records including demographics, clinical presentation, laboratory findings, and thyroid function tests.
  • Periodic monitoring of thyroid function over time.

Main Results:

  • Prevalence at diagnosis: 69.2% euthyroid, 24.5% euthyroid sick syndrome (ESS), 5.8% compensated hypothyroidism, 0.5% primary hypothyroidism.
  • Significant improvement in thyroid function was observed between initial assessment and follow-up (P < .001).
  • Approximately 76.5% of patients with initial ESS normalized thyroid function by the second visit, typically within 1-2 weeks.

Conclusions:

  • Thyroid function tests in newly diagnosed T1DM pediatric patients should be conducted 1-2 weeks post-clinical stabilization.
  • Immediate thyroid evaluation is warranted for T1DM patients with a history of thyroid disease or suggestive clinical signs.
  • Periodic monitoring helps in understanding the transient nature of some thyroid function abnormalities in T1DM.

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
135
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
495
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
220
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.1K